OIRM Kick-start Innovation Investment Program

OIRM_Kick_Start_1024x512_newC3ilogo.png

OBIO is proud to partner with the Ontario Institute for Regenerative Medicine (OIRM), the Centre for Commercialization of Cancer Immunotherapy and Regenerative Medicine (C3i), BioInnovation Fund, Bloom Burton & Co., and Versant Ventures to ensure made-in-Ontario technologies get the strategic support they need to succeed.

Kick-Start will support successful applicants with resources to create an incorporated business, along with market assessments and an IP/commercialization plan. Investment funding of up to $100,000 and expert guidance from partners will help researcher attract early-stage investment and build value for the new company. The program will also link applicants with investors and other private sector expertise needed to attract funding and to develop and market the proposed technology.

Previous
Previous

WELL Health Technologies to Acquire CRH Medical for $373 Million

Next
Next

Flosonics Medical Closes US$14M Financing Round and Expands Board of Directors